ACS is committed to helping combat the global COVID-19 pandemic with initiatives and free resources. Learn More

Michael Sinz

Michael W. Sinz, Ph.D. is a Senior Research Fellow at Bristol Myers Squibb in the department of Metabolism and Pharmacokinetics where he manages ADME and drug transporter characterization and lead optimization in drug discovery (2001-present).  Dr. Sinz previously held the position of Section Director-Pharmacokinetics and Drug Metabolism at Parke-Davis/Pfizer Research and Development (1991-2001).  He received B.S. degrees in Chemistry (ACS) and Biology from the University of Wisconsin-Eau Claire and a Ph.D. in Medicinal Chemistry from the University of Minnesota.  Dr. Sinz is a member of the International Society for the Study of Xenobiotics and American Chemical Society.  He was previously a member of the PhRMA Drug Metabolism group and presently a representative on the Translational ADME Leadership Group of the IQ Consortium.  He is an associate editor for Drug Metabolism Letters, on the editorial advisory boards of Current Pharmacology Reports and Drug Metabolism and Disposition and was previously the editor of Current Drug Metabolism.  His areas of research include in vitro and in vivo drug metabolism, clearance predictions, reaction phenotyping, and drug-drug interactions.  He has published ~100 manuscripts/book chapters and a similar number of presentations on drug metabolism and interactions.